DIP Episode 360 - The Clutch Secondary Hypertension Podcast (Step 1-3)
Topic
Secondary hypertension; Renal artery stenosis (RAS); Primary hyperaldosteronism (Conn syndrome); Cushing's syndrome; MEN syndromes; Endocrine causes of HTN.
Key Takeaway
Understanding the underlying pathophysiology—whether it involves RAAS overactivation, mineralocorticoid receptor agonism, or catecholamine excess—is crucial for diagnosing and managing secondary hypertension in board-style questions.
Episode Notes
Source / episode info
- Episode: 360
- Title: Divine Intervention Episode 360 – The Clutch Secondary Hypertension Podcast (Step 1-3)
- Published: 2022-01-03
- Source: Episode page
One-liner
This episode provides a comprehensive review of secondary causes of hypertension, integrating concepts from renal physiology (RAS workup), endocrinology (Conn syndrome, Cushing's), and genetics (MEN syndromes) to prepare students for complex board-style clinical vignettes.
High-yield summary
- Renal Artery Stenosis (RAS): The hallmark is secondary hyperaldosteronism due to reduced renal perfusion activating the RAAS system; a key pitfall is avoiding ACE inhibitors/AR Bs in bilateral RAS.
- Primary Hyperaldosteronism (Conn Syndrome): Characterized by resistant hypertension, hypokalemia, and metabolic alkalosis; diagnosis relies on an elevated Plasma Aldosterone to Plasma Renin Ratio (ARR) > 30 and failure of aldosterone suppression after saline infusion.
- Cushing's Syndrome: Excess cortisol acts as a mineralocorticoid agonist, leading to sodium/water retention, potassium wasting, hypertension, hypokalemia, and metabolic alkalosis.
- MEN2 Syndrome: The classic triad includes Medullary Thyroid Cancer (MTC), Pheochromocytoma, and Primary Hyperparathyroidism; the catecholamine excess from pheo is a major cause of HTN.
- RAS Differential Diagnosis: Atherosclerosis affects the intima layer, while Fibromuscular Dysplasia (FMD) typically affects the media layer.
- Acute Care/Trauma: Increased Intracranial Pressure (ICP) can trigger Cushing's Triad (Hypertension, Bradycardia, Irregular Respirations) due to CRH release.
Learning objectives
- Differentiate the pathophysiology and diagnostic workup for primary vs. secondary hypertension.
- Identify the specific anatomical differences between atherosclerotic RAS (intima) and fibromuscular dysplasia (media).
- Recognize the classic clinical triad, associated hormones, and genetic basis of MEN2 syndrome.
- Interpret laboratory findings (e.g., Aldosterone/Renin ratio, urinary electrolytes) to diagnose mineralocorticoid excess states.
- Apply knowledge of endocrine axes (HPA axis, RAAS) in acute settings (e.g., increased ICP).
Board exam buzzwords
| Condition | Key Finding | Association | Board Exam Tip |
| Primary Hyperaldosteronism | High Aldosterone/Renin Ratio (>30) | Resistant HTN, Hypokalemia, Metabolic Alkalosis | Always check the ARR first when evaluating resistant hypertension. |
| Cushing's Syndrome | Hypokalemic metabolic alkalosis | Cortisol acting on Mineralocorticoid Receptors (MR) | Remember that cortisol excess mimics aldosterone effects. |
| MEN2 Syndrome | Medullary Thyroid Cancer + Pheochromocytoma | RET proto-oncogene mutation; Catecholamine release | MTC is the most common component found in this syndrome. |
| Licorice ingestion | HTN, Hypokalemia | Inhibition of 11-hydroxylase | This drug/substance mimics mineralocorticoid excess by increasing cortisol activity. |
Rapid review table
| Topic | Key Point | Context | Exam Relevance |
| Renal Artery Stenosis | RAAS activation (Ang II , Aldosterone ) | Reduced renal perfusion pressure due to RAS or Coarctation of the Aorta. | High-yield for board questions; always consider it in HTN workup, especially with Doppler findings. |
| Conn Syndrome | Plasma Aldosterone/Plasma Renin Ratio (ARR) > 30 | Primary adrenal adenoma/hyperplasia causing autonomous aldosterone secretion. | The diagnostic ratio is critical; the salt suppression test confirms autonomy. |
| Cushing's Syndrome | Cortisol excess -> MR activation | Hypercortisolism, regardless of source (e.g., licorice). | Leads to hypokalemia and metabolic alkalosis due to mineralocorticoid effects. |
| MEN2 Syndrome | MTC + Pheochromocytoma + PTH issues | RET gene mutation; Catecholamine excess from pheo. | The triad is highly specific; HTN is driven by catecholamines, not just aldosterone. |
Board-speak -> diagnosis
| Board-speak / Vignette phrase | Diagnosis / Concept | Why it fits |
| Elderly patient with severe HTN and bilateral RAS who worsens significantly after starting an ACE inhibitor. | Bilateral Renal Artery Stenosis (RAS) | AC Ei/AR Bs reduce renal perfusion pressure, exacerbating the already compromised GFR in both kidneys. |
| Resistant hypertension, hypokalemia, metabolic alkalosis, and a high plasma aldosterone to renin ratio (>30). | Primary Hyperaldosteronism (Conn Syndrome) | This constellation points directly to autonomous mineralocorticoid excess, independent of RAAS feedback. |
| A patient with HTN, obesity, striae, proximal muscle weakness, and elevated cortisol levels. | Cushing's Syndrome / Cortisol Excess | High cortisol acts on MR receptors, causing mineralocorticoid effects (HTN, hypokalemia). |
| Medullary thyroid cancer discovered in a patient who also has pheochromocytoma and hyperparathyroidism. | Multiple Endocrine Neoplasia Type 2 (MEN2) | This is the classic triad associated with RET proto-oncogene mutations; catecholamine excess causes HTN. |
| A child presenting with hypertension, requiring Doppler ultrasound of the renal arteries. | Renovascular Hypertension / RAS | In pediatrics, RAS must be ruled out early due to potential for rapid progression and specific management needs (e.g., coarctation). |
| Patient consuming excessive amounts of licorice candy develops HTN and hypokalemia. | Licorice ingestion/Mineralocorticoid Excess | Licorice inhibits 11-hydroxylase, leading to cortisol accumulation and subsequent mineralocorticoid activity. |
Differential diagnosis / distinguishing features
Primary Hyperaldosteronism vs. Secondary Causes of HTN
| Key Features | Distinguishing Findings | Next Step |
| Primary (Conn): High Aldosterone/Renin Ratio (>30); Hypokalemia; Metabolic Alkalosis. | Secondary: Low or normal ARR (e.g., RAS, Cushing's). The cause is external to the adrenal gland. | Measure plasma aldosterone and renin levels before starting any anti-hypertensive agents. |
| Primary: Aldosterone secretion is autonomous/unregulated by RAAS feedback. | Secondary: Renin production or volume status dictates aldosterone release (e.g., low renal perfusion -> high renin). | If the ratio is normal but HTN persists, consider Cushing's syndrome workup. |
Management pearls
- Bilateral RAS Caution: Never initiate ACE inhibitors or AR Bs in patients with bilateral RAS due to the risk of precipitating acute kidney injury (AKI) by severely reducing already compromised renal perfusion pressure.
- Conn Syndrome Workup: The initial screening test for resistant HTN is measuring the Plasma Aldosterone/Plasma Renin Ratio (ARR). A ratio > 30 strongly suggests primary hyperaldosteronism.
- Diagnostic Confirmation: Confirm Conn syndrome with a salt suppression test (or saline infusion); failure of aldosterone levels to suppress confirms autonomy.
- Adrenal Vein Sampling (AVS): This is the definitive diagnostic test for unilateral adrenal adenoma causing Conn syndrome, showing high aldosterone concentration in one vein and normal/suppressed levels in the other.
Don't miss
Integration & clinical reasoning
- Endocrine Integration: The adrenal gland is central; understanding how excess hormones (cortisol, aldosterone, catecholamines) mimic or disrupt normal feedback loops is key to diagnosing secondary hypertension.
- Renal/Cardiovascular Integration: RAS and Coarctation of the Aorta are classic examples where vascular compromise leads to systemic HTN via RAAS activation.
- Pharmacology Integration: The mechanism of action for mineralocorticoid receptor antagonists (e.g., Spironolactone, Eplerenone) directly targets the pathophysiology seen in Conn syndrome.
OMM / COMLEX integration
- Acute/Unstable Management: In any acute setting (e.g., septic shock, severe AKI), the priority is hemodynamic stabilization and addressing immediate life threats. The workup for secondary HTN should be deferred until the patient is stable.
- Adrenal Crisis: While not directly discussed, remember that adrenal insufficiency (primary AI) requires immediate high-dose IV glucocorticoids (hydrocortisone) to prevent circulatory collapse due to mineralocorticoid deficiency.
Concept connections / cross-references
- For detailed information on adrenal gland function and specific endocrine disorders: [ Episode 37 ] (Hypothalamic/Pituitary Axis).
- For comprehensive coverage of kidney physiology and tubular handling: [ Episode 12 ] (Renal Tubular Function).
- For understanding the general principles of hypertension management: [ Episode 5 ] (General Cardiovascular Physiology).
High-yield association table
| Condition | Association | Mechanism | Clinical Significance |
| Primary Hyperaldosteronism | High Aldosterone/Low Renin Ratio (>30) | Autonomous aldosterone secretion -> Na+/H2 O retention, K+ wasting. | Requires definitive diagnosis (AVS) to guide surgical vs. medical management. |
| Cushing's Syndrome | Mineralocorticoid Receptor Agonism | High cortisol levels bind and activate MR, mimicking aldosterone effects. | Causes hypokalemia and metabolic alkalosis; treatment often involves adrenalectomy or anti-mineralocorticoids. |
| MEN2 Syndrome | Medullary Thyroid Cancer + Pheochromocytoma | RET proto-oncogene mutation -> Catecholamine overproduction. | The HTN is due to massive alpha-1 agonist activity, requiring careful alpha-blockade pre-operatively. |
| Licorice Ingestion | Inhibition of 11-hydroxylase | Prevents the conversion of cortisol into inactive metabolites, leading to functional cortisol excess. | A common and easily missed cause of mineralocorticoid excess in board questions. |
Key terms glossary
| Term | Definition | Context | Example |
| Mineralocorticoid Receptor (MR) | Receptor that binds mineralocorticoids (aldosterone, cortisol) leading to Na+ reabsorption and K+/H+ excretion. | HTN/Electrolyte imbalance; Cushing's syndrome. | Spironolactone is an MR antagonist used to treat Conn Syndrome. |
| Plasma Aldosterone/Renin Ratio (ARR) | The ratio of circulating aldosterone levels to plasma renin activity. | Screening for primary hyperaldosteronism. | A ratio > 30 strongly suggests autonomous aldosterone secretion. |
| 11-hydroxylase | Enzyme responsible for converting cortisol into inactive metabolites. | Drug/Substance toxicity; Cushing's workup. | Licorice is a potent inhibitor of this enzyme, causing functional hypercortisolism. |
| Fibromuscular Dysplasia (FMD) | Non-atherosclerotic, non-inflammatory vasculopathy affecting medium-sized arteries. | Differential diagnosis for RAS in younger patients. | Affects the media layer of the artery wall, unlike atherosclerosis which affects the intima. |
Study optimization
| Topic | Study Approach | Priority | Resources |
| Secondary HTN Syndromes | Create flowcharts linking clinical signs (e.g., hypokalemia) to underlying pathophysiology (MR agonism). | High | Review board vignettes focusing on the mechanism of electrolyte disturbance. |
| RAS Workup | Master the differential diagnosis between atherosclerotic and non-atherosclerotic causes, paying attention to vessel layers affected. | Medium-High | Practice interpreting Doppler ultrasound findings in pediatric HTN. |
| Endocrine Emergencies | Memorize the key diagnostic ratios (ARR > 30) and classic triads (MEN2). | High | Use flashcards for "Clinical Presentation -> Diagnosis." |
Question pattern recognition
- Pattern: Resistant Hypertension + Hypokalemia/Metabolic Alkalosis -> Primary Hyperaldosteronism. Always check the ARR. If high, confirm with salt suppression test and consider AVS.
- Pattern: HTN in a child -> Doppler Ultrasound of Renal Arteries. Never assume RAS is not present; it must be ruled out early.
- Pattern: Triad of MTC + Pheochromocytoma + Hyperparathyroidism -> MEN2 Syndrome. The catecholamine excess from pheo drives the HTN, making alpha-blockade paramount for pre-op management.
Test yourself
Common mistakes to avoid
Common traps
Original transcript with highlights
Original transcript with highlights (part 1/6)
Okay, welcome. My name is divine. This is episode 360 of the divine intervention podcast. And this podcast is going to be called the Clotch Secondary Hypertension Podcast. The Clotch Secondary Hypertension Podcast. This is going to be a big time pathophysiology and physiology podcast. It's going to help you integrate many things, put many things together for your respective exams. So this is something I would say is especially pertinent to a person that is taking step one, step two, seek your step three. Before I go into a discussion today, I have a series of courses coming up this month. The first one is if you're taking step one, I have a foundation score. So basically the first set of courses, if you're taking step one or you've taken step one before, and you had a low score and you're trying to build a solid foundation first step two or step three. I do offer a foundation scores. It's going to be taking place from the 31st of January to the 4th of February. And it's going to be from 70 a.m. to noon, mountains, dunder time on each of those days. It's 5 days, 5 hours each day. We're going to review a lot of physiology, a lot of pathophysiology of the different body systems. And again, just making integrations across these systems, ensuring you how these things are classically tested on the exams. It's called a foundation scores because again, we're really going to be focusing a lot on physiology and pathophysiology.
Because again, in my experience, when you have a good solid understanding of those things, it just makes your study process for the USME Ls a lot better. Now, if you're taking step two, seek a or step three, I do offer a 24 hour course. That's going to be taking place from the 25th of January to the 28th of January. So that's 24 hours, it's six hours for four days each. It's from 70 a.m. to 1 p.m. mountains, dunder time on each of those four days. We'll review surgery, pediatrics, OB-guine, psych, neuro, internal medicine, bio-statistics, ethics, professionalism, communications, and we'll also review multi-system processes and disorders. And then on the 24th of January, we're going to be having the NV Me test against strategy scores. Again, many people have taken these courses, they've done extremely well on the exams afterwards. I definitely, definitely have had just an accountable number of stories of people that have done extremely well after taking my course. They even had really big increases in their U-World Cuban percentages. So again, if you're following 20 of those categories, you're taking shelf exams or step two or step three. And you struggle with test against strategies, the course is going to be perfect for you. It's going to be from 2 to 4.30 p.m. mountain standard time on the 24th of January. If you're interested, just ship me an email through the website and I will give you some more information. The courses are going to be held over Zoom.
So let's jump into secondary hypertension. So the thing is, we know that they're in general two kinds of hypertension. So there's primary hypertension or sometimes they call it essential hypertension. That's the one where we don't really know what's causing it, but we just know the person has it. But then secondary hypertension is where you're like, oh, this has an identifiable cause. There's something we can literally point out figures and say, you're the one that causes this person's hypertension. So the thing is, we're just going to go through the common causes that tend to pop up on NBM exams. And again, I will try to make integrations, try to explain physiology, try to explain pathophysiology as we go along. Here's the thing. If you love the way I teach during my podcast, you have a very clear idea of exactly how I'm going to be teaching during my courses. Although we've got a slow pace, people ask questions, their questions are answered, and it's very structured, very form-rated. So let's begin. So what if they give you a question about an 81 year old meal? They tell you that for the last two or three months, he's been having very severe morning headaches. And they tell you that you check his blood pressure, it's like 180 over 100. So that's obviously pretty high. And then they tell you that he has, you can hear brewing when you listen to his flunk, you can hear flung brewing. Well, obviously if you hear that, we know that this is going to be Rinalotri stenosis.
So it's going to be Rinalotri stenosis. The first thing I think I'm going to go ahead and start with is that Rinalotri stenosis, what's the biggest risk factor? What is the biggest risk factor for Rinalotri stenosis? Well, it depends, right? But if I were you on your exams, I would pick smoking as an answer. I would pick smoking as an answer on your test. Oh, pick smoking as an answer on your test. You know, many other things can be risk factors, but really the big one I think I will strongly encourage you to think about on exam says is smoking, right? Again, remember smoking loves to cause a thoraclerotic diseases, right? So the thing is, why will a person on Rinalotri stenosis have hypertension? Well, if you think about it, we have a risk factor. When you have Rinalotri stenosis, you're going to essentially be constructing the afraen material, like the Rinalotri. So you're not sending enough blood to the afraen material, right? And the afraen material has GG cells, the juxtaglimarial cells, they'll freak out, they'll make a ton of reigning, and reigning will lead to the production of a lot of angiotensin 1 and angiotensin 2 and angiotensin 2 and angiotensin 2 is a very powerful viso constrictor. So that's going to raise your blood pressure. And then, our dose from also helps you retain sodium and water from your nephron, from your kidneys. So that's also going to increase your blood volume, and that's going to raise your blood pressure, right?
Remember, Rinalotri stenosis, many times if you want to make the diagnosis, you're going to perform some kind of like Rinalangiography or Rinalatereography to establish the diagnosis. And, you know, one of the way our friends at the NBM is love to talk about Rinalatere stenosis is they actually love to do the stenosis where they will give you a person that will study on an isine inhibitor for hypertension. And you just notice that they're cracking and really goofs up like really bad, right? Because don't get me wrong, if you're pleased on an isine inhibitor or an ARB, an angiotensin 2 receptor blocker, your creatin is going to go up a little bit, right? Because remember, those drugs they dilute the ephronatural. So that's going to lower your GFR, that's going to raise your creatin in a bit. But, the thing is, you know, it raises by like point something, right? If you notice that, wow, this person's creatin was like one, and boom, it's like 2.5, there's something going on there, right? The thing that's going on there is that it presents bilateral Rinalatere stenosis. Remember, when you have bilateral Rinalatere stenosis, you should not be placed on an isine inhibitor or an ARB, right? If not, you can get into some hot order there. So it's very high to know and actually understand that, right? So whenever you have bilateral Rinalatere stenosis, right? The thing is, the reason why isine inhibitors are problematic in these people is that.
Isine inhibitors dilute the ephronatural. That already is going to lower your GFR, because you're essentially reducing the hydrostatic pressures in the glomerular capillaries. But then, at the same time, the person already has Rinalatere stenosis, right? So they are not bringing enough blood to their glomerular capillaries. Again, that is also lowering the hydrostatic pressures in the glomerular capillaries. That's going to lower the GFR, and it's going to bring up the creatin. So literally, you're killing the person on both sides. You're killing them from the aphronatural side. It's already like not getting enough blood. You're killing them from the ephronatural side by diluting it and taking all the blood away, right? So they have no GFR. So those people can go into fluoride renofin. Then, one of the things, one of the ideas that just came to mind with this Rinalatere stenosis business, is they can give you a very similar vignette in a younger person. You see a younger person, they have this hypertension, right? And you just notice that, wow, this person has this hypertension. But in addition to that, you can hear flung brewery, right? Obviously, you'll put Rinalatere stenosis as an answer. That'll be the smart thing for the NBM Institute to do, but you'll be wrong. Usually, it's going to be in a female. It's going to be fibromuscular dysplasia. Remember, fibromuscular dysplasia presents very similarly to Rinalatere stenosis.
But the key thing to know with fibromuscular dysplasia is that the pathophysiology is very different from the pathophase of Rinalatere stenosis. I feel like sometimes med students try to group certain things together that should not be grouped. Yes, the presentation is similar, you know, the age bracket is different. But one of the key differentiating points is knowing the pathophysiology. Remember, arteries have three layers of the wall, right? It's the intima, that's the innermost layer, right? It's intimate, right? So there's the intima, there's the media, that's the muscle layer, the smooth muscle layer, and then there's the adventition. When people have Rinalatere stenosis, it's actually the intima that is affected. It's atherosclerosis of the intima. When people have fibromuscular, look at the name, fibromuscular dysplasia, it's not the intima that is affected, it's the media that is affected, right? They have dysplasia of the smooth muscle cells, right? That's what ultimately causes like a compression of the Rinalatere, right? So it's very high yield to remember. Phyromuscular dysplasia is a problem at the level of the media of the artery. Rinalatere stenosis is a problem at the level of the intima of the artery, right? And again, because these problems are very proximal to the afran arterials, it would make sense that the person's Rinalin is going to be high.
The person's, you know, remember, Rinalin converts angiotensinogen to angiotensin 1, and then angiotensin 1 is converted to angiotensin 2 by angiotensin-converting enzyme, right? And then angiotensin 2 goes to the zonal glomerulosa of the adrenocortex and makes you release ourosterone. So the thing that happens is that the rinalin is going to go up via angiotensin 1 is going to be up, angiotensin 2 is going to be up, and the aldosterone is going to be up as well, right? So the person's PC to PR-A ratio, so the plasma aldosterone to rinalin ratio in those circumstances is going to be usually less than 20 on NV Me exams, right? Now, contrast this with a person that, you know, again, you'll give you this question about a person, if he's been placed on multiple anti-hypertensives, none of them is doing did listquart for the patient. And you then notice that while this person has like hypochylemia, they have anabolic alkylosis, they have like really bad hypertension, usually the sodium is going to be normal on exams. If you see this, what are you thinking about? And many times they will even be kind of say, oh, the plasma aldosterone to rinalin ratio is more than 30, right? If you see this, I would really, really hope you're thinking about con syndrome. Remember, con syndrome is also known as primary hyper-autosteronism. That's a different name for the same disease, right? So con syndrome is also called primary hyper-autosteronism. So what happens in con syndrome?
Well, many times, where you have an adrenaline adenoma, or you may have like adrenaline hyperplasia, and in those situations you make a ton of out-dosterone, well, we know what out-dosterone does. Out-dosterone makes you reabsorb sodium and water in your nephrine. If you do that, you're going to raise your blood volume, because there's more blood moving through you, because you have more blood volume, you're going to have a higher blood pressure, right? So it's an adenoma that's equating a ton of out-dosterone, right? So since your blood pressure is really high, well, if you notice the problem is distal, so the rinal artery, so the presence of blood pressure is really high. So the presence of rinal tear will be hyper-perfused. So those GG cells, those juxtaprimerular cells will freak out and say, ooh, what is going on? Okay, so they will dial down the arrhyening production. They will dial down the angeotensin-1, and the angeotensin-2 production. So notice your out-dosterone is going up, but your arrhyening is going down. So your plasma out-dosterone to arrhyening ratio should be great, should be greater than 30 on an in-be-immig-exam. Right? Again, that's something that's pretty high yield to know for for tests, right? And remember, when the person has a con syndrome, right? Again, you're going to first start off working it up by checking the, you know, you see a patient presents with resistant hypertension, hypokillinum metabolic alcanosis.
Obviously, you're going to start off first by saying, you know, let's check the plasma out-dosterone to arrhyening ratio. That's the thing that just makes logical sense to do first. Again, I feel like many people just memorize our algorithms. We don't really need to, if you just understand what's going on, right? Like just certain steps, make logical sense as the first thing to do before doing other things, right? So the plasma out-dosterone to arrhyening ratio would be more than 30. So you're like, okay, great, fine, whatever. You have con syndrome, but you can confirm it. Remember, many times in medicine, we love screening tests, right? We've screened for con syndrome, but after that, we need to do a diagnostic test. The diagnostic test for con syndrome, right, is something we call a salt suppression test. Because if I take a normal human being like myself and yourself and you get salts like an infusion of a salt solution infusion, your body will be like, ah, your body will try to suppress production of our dosterole, right? So we call this the ceiling infusion test. If I give you an infusion of ceiling, but I notice that your outdoor syndrome does not suppress. So let's say usually, you know, you measure the outdoor syndrome before you infuse the ceiling, you measure the outdoor syndrome after you've infused the ceiling. I notice that while the outdoor syndrome did not drop, then that's diagnostic for con syndrome, right?
Now, the thing is, most times before you take the person for treatment, you know, there's a test you can do that can help you determine, okay, what direction do I take? Because sometimes in con syndrome, they decide to cut out the person's adrenal glands, right? But at some other times, they're like, you know, we're not going to cut out the adrenal glands, we're going to give you an outdoor syndrome antagonist, right? So something like Spirinolatone or your Plierino. Right? So how do they make that judgment call? Well, the way that judgment call is made is by doing something we call adrenal vein sampling, right? Adrenal vein sampling. And adrenal vein sampling, the thing that happens is you look at the person's adrenal vein, so you try to draw some serum from both adrenal veins. The thing is, if you have con syndrome, you want adrenal vein, then your dosterole should be elevated in that one bad adrenal, like in the vein training that bad adrenal gland. But it should be normal, even suppressed in the other adrenal gland that doesn't have issues, right? Because that other adrenal gland does not have an adenomyinit. So those adrenal cortical cells in the adrenal glomerulosa are responsive to normal hypertensive signals because presence hypertensive. So those cells should not be making an outdoor syndrome. So if you do that adrenal vein sampling, you check, you're not like, oh, okay, the adrenal vein on the right has very high outdoor serum.
But one of the left has like very little or nonexistent outdoor serum. That's great. That's unilateral con syndrome. Go ahead and cut off the adrenal gland on the side that has the adrenal vein with a very high outdoor serum. But there are sometimes where people actually both of the adrenal glands are affected, right? For whatever bizarre reason, both adrenal glands are making a ton of outdoor serum. Many times it's going to be from like a bilateral hyperplegia. If you see stuff like this, you cannot cut out both of the persons adrenal glands. That's a very high morbidity, high mortality kind of deal. So the way you're going to all be each of those problems is you're going to give an outdoor serum antagonist. You're going to give something like sperm and lactone where a player you know on endemic exams, right? So again, that diagnostic tree is just one of those things that you love, love, love to test on exams. It's something you absolutely want to make sure you know and actually understand, right? And then just remembering in general, secondary hypertension, you can get it from many other things, right? Like if you have like kidney problems for any reason, right? So let's say you have like chronic kidney disease, right? If you have chronic kidney disease, you're going to be making a ton of rain in it, right? That can cause you to actually have hypertension, right?
When you see a person and they tell you that, oh, maybe one of their family members or their parents died of a stroke like a sub-rock night hemorrhage, right? And then the person has like really bad hypertension. That's pretty straightforward. This person has a lot of dominant, polycystic kidney disease. Remember, those people will tend to get like cis and the liver, cis and the pancreas, cis and the kidneys, right? So many times they can also get like mitral valve prolapse, so that's a hard problem they can get. But in addition to that, they tend to have these aneurysms that build up in the circle of willis. Well, those aneurysms when the pop, right, it's going to make sense that that person has a sub-rock night hemorrhage, right? So just kind of keep those things kind of floating in your mind, right? And then remember, if you also have these glomerular diseases, right? So if you have any of the glomerular nephritis, right? So like post-tractococcal plymerular nephritis or IgN Fropathy, any of those nephritic syndromes, those things classically are going to be associated with hypertension or NBM exams. Again, if you have damage to the kidneys, they can cause you to make a ton of reigning and they can activate the reigning and retention of the strontial system. You'll be hypertensive, many times you'll have hypochylineas, right? And then don't forget, even in kids, kids tend to get these renovascula hypertension, right?
Like if you see a child with an elevated blood pressure, many times on NBM exams, they want you to do like some kind of Doppler ultrasound of the renal artery. Because kids, you see them having hypertension, you want to be worried potentially about those kids having like a renovascula hypertension. So many times again, you're just going to do a Doppler, Doppler of the renal artery just to see like what flow looks like, right? To make sure they have stenosis or not. These are things that can be pretty accurately measured with ultrasound. And then remember again, in kids, some of these tumors they can have, right? So like they have like a WOMS tumor. WOMS tumors, Plastic Lyon NBM, is going to be a stretch of their hypertension, right? Neuroblastomas, those are not kidney tumors, remember neuroblastomas are going to be calcified masses that cross the midline, very high of their calcified masses, and they cross the midline of the body. This is going to be on like a WOMS tumor, which is not calcified, and which does not cross the midline. I'll say that again, WOMS tumors are not calcified, and you do not cross the midline, right? So essentially the thing that's going to be happening here is that the person is, you know, WOMS tumor many times these tumors can make renein, and again that renein can activate the renein and get your tensile dose urine system, and that can make you hyper-hypertensive, right?
And again, also don't forget, if a person has increasing chocretial pressures, right? So they can give you a question about a person, a person who has a monovicol accident, they are barely responsive, and they notice that, oh gee, this person's blood pressure is like 200 over like 120, and your heart rate is like 30, right? And you know, they are altered, right? You can really arouse them. If you see this, right? This person is going to be hurting pretty soon, right? Remember, that's something we call like, it's almost like a reflex, right? That happens when a person's ICP is up, right? They call it like bradycardia, hypertension, and irregular respirations, right? I'll say that again, bradycardia, hypertension, and irregular respirations. Basically, whenever your brain has increased pressures, it causes you to make actually a lot of caracolomins, right? So things like neurobenefit, for example, that's going to cause a very powerful viso-construction, and that can absolutely raise your blood pressure, right? They can absolutely raise your blood pressure. And then, don't forget, I mean, certain endocrine problems, right? Like, they can give you a question about a person, you know, they tell you that, you know, multiple family members of heart thyroid cancer, and then this person just has these episodes of like, really bad headache, really bad heart blood pressure. If you see that, right, there's going to be a few chromosyptoma, right?
Obviously, this person has one of these medallary thyroid cancers, right? You have one of these MEN syndrome, so I'm actually going to be a little more specific there. It's probably going to be MEN2, too, right? Because remember, you don't get medallary thyroid cancer in MEN1, getting MEN2. So the thing is, this person very, very likely has MEN2, right? Remember, in MEN2, it's like a regin notation. You're going to have like medallary thyroid cancer, you're going to have few chromosyptomas, you're going to have primary hyperparthyroidism. And then, if you look at MEN2 B, that's where you're going to have like the, you know, the fiochromosyptomas, martyronoid habitats, medallary thyroid cancer, and also have those mucosone aromas. Again, that's also a regin mutation, or there's a more dominant inheritance, right? So, again, you feel chromosyptomas, right? You have like some tumor that's making a ton of caricola means, making things like nirvanaferine, making things like nirvanaferine. And again, those things, they are very powerful alpha-1 agonists, right? If you activate alpha-1 receptors, that's going to cause a very powerful visual constriction, that's going to jack up your systemic vascular resistance, and that's going to cause hypertension, right? It's going to cause hypertension. And also, if you have pushing syndrome, right?
So, they can give you some question about a person that you know has a buffalo hump, or the person has like hyperdocemia, or the material that the person has like a fracture of the hair, right? Like evasculinacrosis, right? You know, they can tell you about a woman that's in her 40s, that is very obese, that's having all these recurring fractures, right? Because remember, cortisol kind of kills your bone mineral density, right? All those, you know, cortisol can absolutely cause hypertension, right? So, you can already see how many ways they can test these things, right? They can give you a person of peptic ulcer disease, right? Remember, hypercordysol is in causessa, and increase in gastric acid secretion, or is this going to cause you to have peptic ulcer disease? But basically, when you have high cortisol, you absolutely positively can get hypertension, because remember, cortisol, especially when you have very high concentrations of it, typically it can actually cause you to, it actually has like some mild mineralocorticoid receptor activity. So, literally, what am I saying by that? cortisol has the ability to act on our dose-troner receptors, right? Our dose-troner receptors. So, the thing that happens in those circumstances is, as cortisol activates our dose-troner receptors, you're going to get an, our dose-tron-like effect. So, you're going to get, you're going to get hypertension. You're going to get hypochyline, you're going to get a metabolic alkalosis.
Because remember, our dose-tron, one of its job, it's many jobs, right? You know, it retains sodium and water, so it raises your blood pressure, but it makes you, you're in it potassium, and it makes you, you're in it hydrogen ions. So, whenever you're in it in potassium, you're going to have hypochyline, whenever you're in it in hydrogen ions, you're going to get a metabolic alkalosis, right? So, those are all the wonderful things that our dose-troner can do. So, again, whenever you have cortisol excess, you're going to have increased mineralocorticoid receptor activity. That's absolutely going to cause issues, right? In fact, this cortisol excess thing that they can discuss, you know, our friends at the NBM is, they're pretty smart, right? So, they can give you some random question about a child, right? And they tell you that this child, or like young adult, or teenager, or whatever, has this really high blood pressure, right? And you know, they've noticed these high blood pressures, and they give you some temporal association in the question that, oh, wow, this person has been eating a lot of candy, candy, candy in recent times. Well, what's causing that problem? It's going to be licorice, right? Licorice is L-I-C-O-R-I-C-E. I'll say that, I'll spell that again. L-I-C-O-R-I-C-E, right? So, licorice, you can actually have some candy that's made of licorice. Well, how does licorice cause people to be hypertensive?
Well, remember, I just said that cortisol has the ability to act on mineralocorticoid receptors. Well, the body knows there is the body is like, you know what, I don't really want to be hypertensive. So, what does your body do? Well, the thing your body does is that actually has an enzyme. That enzyme is known as 11 beta hydroxy steroid dehydrogenase, right? 11 beta hydroxy steroid dehydrogenase. That's an enzyme that converts cortisol to cortisol. The thing is cortisol has the ability to activate mineralocorticoid receptors. Cortisol does not have the ability to activate mineralocorticoid receptors. But the thing is, when you consume a ton of licorice, licorice is a very powerful inhibitor of 11 beta hydroxy steroid dehydrogenase. When you give it 11 beta hydroxy steroid dehydrogenase, then you're going to have a persistence of cortisol and that's going to cause hypertension. Because again, cortisol has agonist activity, mineralocorticoid receptors. And also, if you just have some mutation where you have some loss of function problem with that 11 beta hydroxy steroid dehydrogenase, that's also going to cause you to have issues, right? And then, our friends at the MV Mines, I mean, again, they're really smart. They can give you a question about some girl that has really high blood pressure. And they tell you that, oh, they do some serum studies. And they notice that she has increased levels of 11 deoxyquaticostero. The girl would not have an biggest genitalia.
She's not going to have signs of heralization. Well, if you see this, then I really hope you're saying, hmm, and then they can, if you give you all these other signs of hypocortisolism, so even those of you who are seeing hypocortisolism, so you'll notice that they are hypertensive, but they're like hypocortisolism. So even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so even those of you who are seeing hypocortisolism, so if for example you have like 11 beta hydroxylase deficiency or 17 hydroxylase deficiency, right? That's gonna cause you to have, that's gonna cause you to have a a a
a
a a a
a a a a a a a a a a a a
a a
a a a a a a a a a a a a a a
a
a a a
a a a a a a a a a
a a
a a a a a a a a a
a a a a
a
a
a
a a a a a a a a a a a
a a
a a a a a
a a a a
a
a a a a
a
a a a
a a a a a a a a a
a a
a a
a
a
a
a
a
a
a
a
a
a a a
a
a
a a
a a
a
a
a a
a a a
a a
a a
a a
a
a
a
a
a
a
a a a a
a
a
a a
a a a a a a
a a a
a a
a a
a
a a
a
a
a a
a
a a
a
a
a
a a a
a a a a a a a a a
a a
a a
a a
a
a
a
a a
a
Original transcript with highlights (part 2/6)
a a
a a
a
a a a
a a a a a a a a a
a a
a a a a
a
a
a
a
a
a
a a
a
a
a
a
a a
a a
a
a
a
a a a a
a a
a a
a a
a
a
a
a a
a
a
a
a a
a
a a a
a a
a
a
a
a
a a a
a a
a
a
a
a
a
a
a
a
a
a
a a
a
a
a
a
a a
a a a
a
a
a a a a
a a
a a
a
a
a
a a
a a
a
a a
a
a
a
a a a
a a a a a a a a a
a a a a a a a
a
a
a
a
a
a a a a
a
a
a a
a a
a
a a
a
a a a
a a
a a
a
a
a
a
a
Original transcript with highlights (part 3/6)
a
a
a
a
a
a
a
a
a
a a
a a
a
a
a
a
a a a
a a
a a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a a
a a
a
a
a
a
a a a
a a
a
a
a
a
a
a
a
a
a
a
a a
a
a
a
a
a a
a a
a
a
a a
a a a
a a
a a
a
a a
a
a
a
a
a
a
a a a
a
a a a
a a a a a a
a a a
a a
a a
a
a
a
a
a
a a a
a a
a
a
a
a
a a a a a a
a a
a a a
a a
a a
a a a
a
a
a
a
a
Original transcript with highlights (part 4/6)
a
a
a
a
a
a
a
a
a a
a
a
a
a
a a a
a a
a a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a a
a a
a
a
a
a a a a
a a
a a
a a a
a
a
a a
a
a a
a
a
a
a a a
a a a a a a a a a
a a
a a
a
a a
a
a
a
a
a
a
a
a a
a
a
a a
a a
a
a
a
a a a a
a a
a a
a
a
a
a
a
a a a
a
a
a a
a
a
a a a a a a a a
a a a
a a a a a
a a a
a
a a a
a a a
a
a
a
a a
a a
a a a a a a a
a a a a a a a a a
a a
a
a a a
a
Original transcript with highlights (part 5/6)
a
a a a
a a a a a a a a a
a a a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a
a a a
a a
a a
a a a
a
a
a a
a
a a
a a
a
a a a
a a
a a
a a
a a a
a a a a a a
a
a
a
a a a
a a a
a
a
a a a
a a
a a
a a
a a a
a a
a a
a
a
a
a
a
a
a
a
a a
a
a
a
a a a
a a
a
a
a
a
a a a
a a
a a
a
a
a
a
a
a a
a
a a
a
a
a
a a a
a a
a
a
a
a a a a
a a
a a
a a a
a
Original transcript with highlights (part 6/6)
a
a a
a
a a
a a
a
a a a
a a a a a a a a a
a a
a a
a
a
a
a
a
a
a
a
a a
a
a
a
a
a a
a a
a a
a
a a a a
a a
a a
a a
a
a
a
a
a
a
a a
a
a
a
a
a
a
a a
a
a
a
a
a a a
a a
a a
a
a a
a
a
a a
a
a
a
a a
a
a a a
a a a a a a
Practice questions — USMLE style
Question 1 — Endocrine/Nephrology
A 58-year-old man presents with resistant hypertension and chronic symptoms of muscle weakness. Laboratory studies reveal hypokalemia, metabolic alkalosis, and a markedly elevated plasma aldosterone concentration (PAC) coupled with a suppressed renin activity. The patient's plasma aldosterone to plasma renin activity ratio is calculated to be greater than 30. Which condition is most likely responsible for this constellation of findings?
- A) Primary hyperaldosteronism (Conn syndrome)
- B) Cushing syndrome due to adrenal adenoma
- C) Secondary hyperaldosteronism secondary to chronic kidney disease
- D) Pheochromocytoma causing volume expansion
Answer: A. Explanation: The classic triad of resistant hypertension, hypokalemia, and metabolic alkalosis, combined with a high PAC/low renin ratio (>30), strongly suggests primary hyperaldosteronism (Conn syndrome). In this condition, the adrenal gland autonomously produces excess aldosterone, leading to sodium and water retention (raising blood volume and pressure) while simultaneously causing potassium wasting and hydrogen ion loss.
Question 2 — Nephrology
A 78-year-old male with a history of smoking presents to the emergency department with severe morning headaches and a blood pressure reading of 180/100 mm Hg. On physical examination, the clinician hears a bruit over the left renal artery. The patient is being considered for an ACE inhibitor (e.g., lisinopril) to manage his hypertension. Given the clinical picture, what critical precaution must be taken regarding the use of RAAS inhibitors?
- A) Monitor potassium levels closely, as hyperkalemia is expected due to impaired aldosterone function.
- B) Avoid all RAAS inhibitors because bilateral renal artery stenosis will precipitate acute kidney injury (AKI).
- C) Use an ARB instead of an ACE inhibitor, as AR Bs are safer in the setting of suspected renovascular disease.
- D) Perform a Doppler ultrasound before starting any medication, as this is the definitive diagnostic test for stenosis.
Answer: B. Explanation: The patient's symptoms (hypertension, bruits, morning headaches) suggest renal artery stenosis (RAS). RAS causes decreased renal perfusion, leading to massive activation of the Renin-Angiotensin-Aldosterone System (RAAS). In cases of bilateral RAS, administering an ACE inhibitor or ARB is extremely dangerous because these drugs reduce efferent arteriolar resistance. Since the kidney already has poor blood flow (low hydrostatic pressure) due to stenosis, reducing systemic vascular resistance further compromises glomerular filtration rate (GFR), potentially leading to acute renal failure.
Question 3 — Endocrinology
A young woman presents with refractory hypertension and chronic symptoms of gastrointestinal upset. She reports consuming large amounts of licorice root candy over the past few months. Laboratory workup reveals hypokalemia, metabolic alkalosis, and normal serum sodium levels. The underlying pathophysiology linking her dietary intake to her blood pressure elevation is due to:
- A) Licorice inhibiting 11$\beta$-hydroxylase, leading to accumulation of mineralocorticoid precursors.
- B) Licorice acting as a direct agonist on the aldosterone receptor in the collecting duct.
- C) Licorice inhibiting $11\beta$-hydroxysteroid dehydrogenase type 2, allowing cortisol to bind and activate mineralocorticoid receptors.
- D) Licorice causing volume depletion, which subsequently triggers excessive renin release and RAAS activation.
Answer: C. Explanation: Cortisol is normally metabolized by the enzyme $11\beta$-hydroxylase into inactive cortisone. However, licorice root contains compounds that are potent inhibitors of this enzyme ($11\beta$-hydroxysteroid dehydrogenase). This inhibition leads to an accumulation and persistence of cortisol in circulation. Because cortisol possesses weak mineralocorticoid activity, its excess action on the mineralocorticoid receptors mimics hyperaldosteronism, causing sodium retention, volume expansion, hypertension, hypokalemia, and metabolic alkalosis.
Question 4 — Endocrinology/Neurosurgery
A 35-year-old man is diagnosed with a neuroendocrine tumor of the adrenal medulla. He presents with paroxysmal episodes of severe headache, palpitations, and profound hypertension. Furthermore, he has a family history positive for primary hyperparathyroidism and pheochromocytoma. Which MEN syndrome best explains this patient's constellation of findings?
- A) Multiple Endocrine Neoplasia type 1 (MEN1)
- B) Multiple Endocrine Neoplasia type 2 A (MEN2 A)
- C) Multiple Endocrine Neoplasia type 2 B (MEN2 B)
- D) MEN syndrome due to primary adrenal hyperplasia
Answer: B. Explanation: The patient presents with a tumor of the adrenal medulla (pheochromocytoma), hyperparathyroidism, and an associated endocrine disorder. This triad is characteristic of Multiple Endocrine Neoplasia type 2 A (MEN2 A). MEN2 A typically involves medullary thyroid carcinoma (MTC), pheochromocytoma, and primary hyperparathyroidism. While MEN2 B also includes MTC and pheochromocytoma, it uniquely adds parathyroid hyperplasia/adenoma and mucosal neuromods, making MEN2 A the most common and classic answer for this specific triad in board questions.
Quick fire review
What are the three components of Cushing's Triad?
Bradycardia, Hypertension, and Irregular Respiration (due to increased ICP).
In RAS, why is ACE inhibitor use dangerous?
Because it exacerbates renal hypoperfusion by reducing efferent arteriolar pressure, risking acute kidney injury.
What enzyme deficiency causes high cortisol but low aldosterone?
11$\beta$-hydroxylase deficiency (or 17$\alpha$-hydroxylase deficiency).
What is the diagnostic test for Conn syndrome that confirms autonomous aldosterone secretion?
Salt suppression test (failure of aldosterone to suppress after saline infusion).
Which MEN2 component releases powerful alpha-1 agonists causing severe hypertension?
Pheochromocytoma/Paraganglioma.
What layer of an artery is affected by Fibromuscular Dysplasia, and what layer is affected by typical atherosclerosis in RAS?
FMD affects the media; Atherosclerosis affects the intima.
What are the key findings (ratios) suggesting primary hyperaldosteronism (Conn syndrome)?
Aldosterone/Renin ratio > 30, along with hypokalemia and metabolic alkalosis.
If a patient has bilateral RAS, what class of antihypertensive drug must be avoided due to risk of acute kidney injury?
ACE inhibitors or AR Bs.
What is the key difference in pathophysiology between Fibromuscular Dysplasia (FMD) and Atherosclerosis-related RAS?
FMD affects the tunica media; Atherosclerosis affects the intima.
Which specific MEN2 syndrome involves Medullary Thyroid Cancer, Parathyroid issues, AND Mucinous Nevi/Osteomas?
MEN2 B.
What is the mechanism by which licorice causes hypertension?
Licorice inhibits 11$\beta$-hydroxylase, leading to increased circulating cortisol activity (which has mineralocorticoid receptor agonist activity).
When performing Adrenal Vein Sampling for Conn syndrome, what finding confirms unilateral disease?
High aldosterone levels in one adrenal vein and suppressed/normal levels in the contralateral vein.
Quick recall / Anki-style questions
What are the key findings (ratios) suggesting primary hyperaldosteronism (Conn syndrome)?
Aldosterone/Renin ratio > 30, along with hypokalemia and metabolic alkalosis.
If a patient has bilateral RAS, what class of antihypertensive drug must be avoided due to risk of acute kidney injury?
ACE inhibitors or AR Bs.
What is the key difference in pathophysiology between Fibromuscular Dysplasia (FMD) and Atherosclerosis-related RAS?
FMD affects the tunica media; Atherosclerosis affects the intima.
Which specific MEN2 syndrome involves Medullary Thyroid Cancer, Parathyroid issues, AND Mucinous Nevi/Osteomas?
MEN2 B.
What is the mechanism by which licorice causes hypertension?
Licorice inhibits 11$\beta$-hydroxylase, leading to increased circulating cortisol activity (which has mineralocorticoid receptor agonist activity).
When performing Adrenal Vein Sampling for Conn syndrome, what finding confirms unilateral disease?
High aldosterone levels in one adrenal vein and suppressed/normal levels in the contralateral vein.